E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
Completed · Phase 3 · Has a placebo group
Conditions studied: Heartburn
In brief
The purpose of this study is to investigate the safety and efficacy of rabeprazole 10 mg in treating frequent heartburn.
Key facts
- Study ID
- NCT00236197
- Run by
- Eisai Inc.
- People needed
- 619
- Starts
- 2005-10-01
- Expected to finish
- 2008-06-01
- Last updated by the study team
- 2009-11-11
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- New York Center For Clinical Research — Lake Success, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.